BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30860192)

  • 1. Towards zero mortality in sickle cell pregnancy: A prospective study comparing haemoglobin SS and AA women in Lagos, Nigeria.
    Babah OA; Aderolu MB; Oluwole AA; Afolabi BB
    Niger Postgrad Med J; 2019; 26(1):1-7. PubMed ID: 30860192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity and mortality in sickle cell pregnancies in Lagos, Nigeria: a case control study.
    Afolabi BB; Iwuala NC; Iwuala IC; Ogedengbe OK
    J Obstet Gynaecol; 2009 Feb; 29(2):104-6. PubMed ID: 19274540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pattern of sickle cell disease in pregnancy in Lagos, Nigeria.
    Ogedengbe OK; Akinyanju O
    West Afr J Med; 1993; 12(2):96-100. PubMed ID: 8398940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal morbidity and mortality associated with mode of delivery in sickle cell disease.
    Martinborough T; Allen-Davis W; Hunter-Greaves T; Thame M; Reid M; Simms-Stewart D
    J Obstet Gynaecol; 2022 Nov; 42(8):3560-3567. PubMed ID: 36541410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcome in HbSS-sickle cell disease in Lagos, Nigeria.
    Odum CU; Anorlu RI; Dim SI; Oyekan TO
    West Afr J Med; 2002; 21(1):19-23. PubMed ID: 12083064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin, thromboxane and glomerular filtration rate are abnormal in sickle cell pregnancy.
    Obilade OA; Akanmu AS; Broughton Pipkin F; Afolabi BB
    PLoS One; 2017; 12(9):e0184345. PubMed ID: 28880908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy.
    Okusanya BO; Oladapo OT
    Cochrane Database Syst Rev; 2013 Dec; (12):CD010378. PubMed ID: 24297507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Description of criteria for near miss in high-complexity obstetric population with sickle cell anemia: an observational study.
    Burgos Luna JM; Páez Rúa DM; Ruiz Ordoñez I; Fernández PA; Escobar Vidarte MF
    J Matern Fetal Neonatal Med; 2020 Mar; 33(6):941-946. PubMed ID: 30231783
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy (PIPSICKLE): a randomised controlled trial (study protocol).
    Afolabi BB; Babah OA; Adeyemo TA; Odukoya OO; Ezeaka CV; Nwaiwu O; Oshodi YA; Ogunnaike BA
    BMJ Open; 2021 Aug; 11(8):e047949. PubMed ID: 34389570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidisciplinary care results in similar maternal and perinatal mortality rates for women with and without SCD in a low-resource setting.
    Oppong SA; Asare EV; Olayemi E; Boafor T; Dei-Adomakoh Y; Swarry-Deen A; Mensah E; Osei-Bonsu Y; Crabbe S; Musah L; Hayfron-Benjamin C; Covert B; Kassim AA; James A; Rodeghier M; Audet C; DeBaun MR
    Am J Hematol; 2019 Feb; 94(2):223-230. PubMed ID: 30456766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The obstetric performance of sickle cell disease patients and homozygous hemoglobin C disease patients in Ile-Ife, Nigeria.
    Dare FO; Makinde OO; Faasuba OB
    Int J Gynaecol Obstet; 1992 Mar; 37(3):163-8. PubMed ID: 1351002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcome in homozygous sickle cell disease: observations from the Jamaican Birth Cohort.
    Lewis G; Thame M; Howitt C; Hambleton I; Serjeant GR
    BJOG; 2021 Sep; 128(10):1703-1710. PubMed ID: 33683802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of live neonates in maternal sickle cell haemoglobinopathy in Ghana.
    Addai FK; Wilson JB; Quashie FJ
    Trop Geogr Med; 1992 Oct; 44(4):312-6. PubMed ID: 1295139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal and foetal outcome of pregnant patients with sickle cell anaemia at Kenyatta National Hospital Nairobi. A retrospective study.
    Aluoch JR; Rogo K; Otieno MB
    Trop Geogr Med; 1990 Jan; 42(1):28-31. PubMed ID: 2260193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia.
    Sun PM; Wilburn W; Raynor BD; Jamieson D
    Am J Obstet Gynecol; 2001 May; 184(6):1127-30. PubMed ID: 11349177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis.
    Oteng-Ntim E; Meeks D; Seed PT; Webster L; Howard J; Doyle P; Chappell LC
    Blood; 2015 May; 125(21):3316-25. PubMed ID: 25800049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome.
    Howard RJ; Tuck SM; Pearson TC
    Br J Obstet Gynaecol; 1995 Dec; 102(12):947-51. PubMed ID: 8652484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcome in women with sickle cell - a five year review.
    Omo-Aghoja IO; Okonofua FE
    Niger Postgrad Med J; 2007 Jun; 14(2):151-4. PubMed ID: 17599116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of Pregnancy in Saudi Women with Sickle Cell Disease Attending the Tertiary Care University Hospital in Eastern Province of Saudi Arabia.
    Haseeb YA; Al Qahtani NH
    Afr J Reprod Health; 2019 Sep; 23(3):42-48. PubMed ID: 31782630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.